Evidence supporting the use of: Avocado
For the health condition: Macular Degeneration

Links: Go back one page, Tool main page, Ingredients list, Health conditions list, Body systems list

Synopsis

Source of validity: Scientific
Rating (out of 5): 2

Avocado has gained interest in the context of age-related macular degeneration (AMD) due to its high content of carotenoids, particularly lutein and zeaxanthin. These carotenoids are antioxidants that accumulate in the macula of the eye and are believed to help protect against oxidative damage associated with AMD. Several small clinical studies and observational data suggest that dietary intake of lutein and zeaxanthin is associated with increased macular pigment density, which is linked to a reduced risk of AMD progression.

One randomized controlled trial (Johnson et al., 2016, Journal of Nutrition) found that daily consumption of one avocado for six months significantly increased macular pigment density and serum lutein levels in healthy older adults. However, these studies largely focused on intermediate endpoints (like macular pigment density) rather than direct prevention or treatment of AMD. There is limited direct evidence that eating avocado itself slows or reverses AMD, but its role as a source of bioavailable lutein provides a plausible mechanism for benefit.

In summary, while avocado is not a traditional remedy for AMD, and the evidence is not robust enough to recommend it as a primary treatment, its inclusion in the diet may support eye health due to its carotenoid content. Evidence supporting its use is promising but limited, warranting a rating of 2 out of 5.

More about Avocado
More about Macular Degeneration

Products containing Avocado

We currently have no products on Vitabase that contain this ingredient.